Prof Pier Guiseppe Pelicci presents at ecancer's Milan Summit on Precision Medicine 2018 about the challenges of personalised oncology.
He discusses the progress of the ACC Italian Program of Personalised Medicine.
He also presents ideas for strategies which could combat some of the challenges faced in personalised oncology.
Prof Pelicci finishes by addressing the Nat1 screening for lung cancer and ongoing initiatives.
The webcast has been supported by an unrestricted educational grant from Roche Foundation Medicine